CPA CPA - ContraFect Corp Chief Officer

Insider

CPA CPA is Chief Officer of ContraFect Corp
Age 49
Phone914 207 2300
Webhttps://www.contrafect.com

ContraFect Corp Management Efficiency

The company has return on total asset (ROA) of (1.1744) % which means that it has lost $1.1744 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.0875) %, meaning that it created substantial loss on money invested by shareholders. ContraFect Corp's management efficiency ratios could be used to measure how well ContraFect Corp manages its routine affairs as well as how well it operates its assets and liabilities.
ContraFect Corp currently holds 2.88 M in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. ContraFect Corp has a current ratio of 1.79, which is within standard range for the sector. Note, when we think about ContraFect Corp's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Ronald DundoreWindtree Therapeutics
69
Gerald ProehlDermata Therapeutics
66
John CPAWindtree Therapeutics
60
MPA MDUnicycive Therapeutics
52
Robert McRaePalisade Bio
N/A
Annie RasmussenAllarity Therapeutics
67
Gordon JDQuoin Pharmaceuticals Ltd
61
James RolkeRevelation Biosciences
56
Joan BrownAllarity Therapeutics
70
Diane EsqWindtree Therapeutics
55
CPA CTPCns Pharmaceuticals
44
Tomasz GeorgeVirax Biolabs Group
40
James FosterVirax Biolabs Group
40
Carol OdleRevelation Biosciences
N/A
MD FAAAAIPalisade Bio
N/A
Donald PickerCns Pharmaceuticals
79
James JDAllarity Therapeutics
55
Professor MDAllarity Therapeutics
67
Claus PedersenAllarity Therapeutics
52
MD DrScAllarity Therapeutics
81
John CPAUnicycive Therapeutics
63
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. Contrafect operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. ContraFect Corp (CFRX) is traded on NASDAQ Exchange in USA and employs 23 people.

Management Performance

ContraFect Corp Leadership Team

Elected by the shareholders, the ContraFect Corp's board of directors comprises two types of representatives: ContraFect Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ContraFect. The board's role is to monitor ContraFect Corp's management team and ensure that shareholders' interests are well served. ContraFect Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ContraFect Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, Chief Officer
SPHR PHR, VP HR
Natalie JD, Corp Counsel
Gary Woodnutt, VP Devel
FACP FACP, CEO Chairman

ContraFect Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ContraFect Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in ContraFect Stock

If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments